Finance

Beta
Lists
AC6:FRA
AlzeCure Pharma AB
€0.084
-0.71%
(-0.00060) 1D
Jun 3, 8:08:32 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AC6...
Open
€0.08
High
€0.08
Low
€0.08
Mkt. cap
153.99M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.44
52-wk low
€0.08
No. of employees
10
Open
€0.08
High
€0.08
Low
€0.08
Mkt. cap
153.99M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.44
52-wk low
€0.08
No. of employees
10
News stories
From sources across the web
About AlzeCure Pharma AB
CEOMartin Jönsson
Employees10
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitealzecurepharma.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.96M
7.71M
16.11M
20.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.04M
2.36M
2.91M
3.34M
Operating expense
9.80M
10.05M
18.05M
21.77M
Total operating expenses
9.80M
10.05M
18.05M
21.77M
Operating income
-9.80M
-10.05M
-18.05M
-21.77M
Other non operating income
-
-
-
-
EBT including unusual items
-9.74M
-10.03M
-17.75M
-21.70M
EBT excluding unusual items
-9.74M
-10.03M
-17.75M
-21.70M
Income tax expense
-
-4.00K
-4.00K
-2.00K
Effective tax rate
-
0.04%
0.02%
0.01%
Other operating expenses
-198.00K
-15.00K
-971.00K
-2.25M
Net income
-9.74M
-10.02M
-17.74M
-21.70M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
67.00K
102.00K
194.00K
143.00K
Interest expense
-1.00K
-66.00K
-62.00K
-58.00K
Net interest expenses
66.00K
36.00K
132.00K
85.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.77M
-9.74M
-17.75M
-21.47M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer